Peregrine Capital Management LLC Buys 17,632 Shares of Guardian Pharmacy Services, Inc. $GRDN

Peregrine Capital Management LLC increased its stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 8.2% in the 3rd quarter, Holdings Channel reports. The fund owned 232,011 shares of the company’s stock after buying an additional 17,632 shares during the quarter. Peregrine Capital Management LLC’s holdings in Guardian Pharmacy Services were worth $6,086,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. SG Americas Securities LLC purchased a new position in shares of Guardian Pharmacy Services in the 3rd quarter worth about $133,000. State of Wyoming bought a new stake in Guardian Pharmacy Services in the 2nd quarter worth approximately $58,000. State of Tennessee Department of Treasury purchased a new stake in Guardian Pharmacy Services in the second quarter worth approximately $186,000. Man Group plc bought a new position in Guardian Pharmacy Services during the second quarter valued at approximately $626,000. Finally, Lazard Asset Management LLC raised its stake in shares of Guardian Pharmacy Services by 53.3% during the second quarter. Lazard Asset Management LLC now owns 296,659 shares of the company’s stock worth $6,321,000 after acquiring an additional 103,146 shares in the last quarter.

Analyst Ratings Changes

A number of brokerages have recently weighed in on GRDN. Oppenheimer assumed coverage on shares of Guardian Pharmacy Services in a report on Friday, October 10th. They issued an “outperform” rating and a $30.00 price objective for the company. Truist Financial lifted their target price on shares of Guardian Pharmacy Services from $30.00 to $34.00 and gave the stock a “buy” rating in a research report on Friday, November 14th. Weiss Ratings restated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research report on Monday, December 29th. Finally, Wall Street Zen upgraded Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a report on Monday, November 17th. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $30.67.

Guardian Pharmacy Services Trading Down 2.3%

Shares of Guardian Pharmacy Services stock opened at $30.23 on Friday. The company’s fifty day simple moving average is $29.83 and its two-hundred day simple moving average is $26.12. The company has a market cap of $1.91 billion, a P/E ratio of 47.98 and a beta of 0.96. Guardian Pharmacy Services, Inc. has a 12-month low of $17.78 and a 12-month high of $37.43.

Guardian Pharmacy Services (NYSE:GRDN) last posted its earnings results on Monday, November 10th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.24 by $0.01. Guardian Pharmacy Services had a net margin of 2.90% and a return on equity of 30.29%. The firm had revenue of $377.43 million during the quarter, compared to analysts’ expectations of $381.16 million. Analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.